14.28
0.62 (4.54%)
| Previous Close | 13.66 |
| Open | 13.69 |
| Volume | 20,561 |
| Avg. Volume (3M) | 112,914 |
| Market Cap | 389,883,168 |
| Price / Sales | 6.37 |
| Price / Book | 4.79 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2026 |
| Profit Margin | -76.05% |
| Operating Margin (TTM) | -56.13% |
| Diluted EPS (TTM) | -0.970 |
| Quarterly Revenue Growth (YOY) | 100.30% |
| Total Debt/Equity (MRQ) | 53.19% |
| Current Ratio (MRQ) | 6.48 |
| Operating Cash Flow (TTM) | -26.21 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Carlsmed, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | 2.5 |
| AI Insight | NA |
| Weighted Average | -0.79 |
Select this tab to load the latest available analysis.
|
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| % Held by Insiders | 4.06% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Palumbo Wealth Management Llc | 30 Jun 2026 | 267,298 |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |